Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development

2020 ◽  
Vol 251 (1) ◽  
pp. 74-86 ◽  
Author(s):  
Anthony W‐H Chan ◽  
Yi Pan ◽  
Joanna H‐M Tong ◽  
Raymond W‐M Lung ◽  
Johnny S‐H Kwan ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Tyrosine Kinase ◽  
Receptor Tyrosine Kinase ◽  
Cancer Development ◽  
Serrated Pathway

scholarly journals Metallopeptidase inhibitor 1 (TIMP‐1) promotes receptor tyrosine kinase c‐Kit signaling in colorectal cancer

2019 ◽  
Vol 13 (12) ◽  
pp. 2646-2662 ◽  
Author(s):  
Cathrine Nordgaard ◽  
Sophia Doll ◽  
Ana Laura de Souza Almeida Matos ◽  
Mikkel Høeberg ◽  
Julhash Uddin Kazi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Tyrosine Kinase ◽  
Receptor Tyrosine Kinase ◽  
Kinase C

The anti-leukemic drug nilotinib inhibits metastatic properties of colorectal cancer cells by targeting the receptor tyrosine kinase DDR1

2016 ◽  
Vol 61 ◽  
pp. S148-S149
Author(s):  
P. Tosti ◽  
C. Leroy ◽  
M. Jeitany ◽  
V. Simon ◽  
D. Bonenfant ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Tyrosine Kinase ◽  
Cancer Cells ◽  
Receptor Tyrosine Kinase ◽  
Colorectal Cancer Cells

scholarly journals The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer

PLoS ONE ◽  
2017 ◽  
Vol 12 (7) ◽  
pp. e0179979 ◽  
Author(s):  
Diana J. Uribe ◽  
Edward K. Mandell ◽  
Adam Watson ◽  
Jesse D. Martinez ◽  
Jonathan A. Leighton ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Tyrosine Kinase ◽  
Receptor Tyrosine Kinase ◽  
Migration And Invasion

scholarly journals Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer

Oncotarget ◽  
2019 ◽  
Vol 10 (13) ◽  
pp. 1320-1333 ◽  
Author(s):  
Ramona Graves-Deal ◽  
Galina Bogatcheva ◽  
Saba Rehman ◽  
Yuanyuan Lu ◽  
James N. Higginbotham ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Broad Spectrum ◽  
Receptor Tyrosine Kinase ◽  
Targeted Therapies ◽  
Kinase Inhibitors ◽  
De Novo ◽  
Receptor Tyrosine Kinase Inhibitors

scholarly journals mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism

2017 ◽  
Vol 24 (6) ◽  
pp. 1045-1062 ◽  
Author(s):  
Aikaterini Lampada ◽  
James O'Prey ◽  
Gyorgy Szabadkai ◽  
Kevin M Ryan ◽  
Daniel Hochhauser ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Tyrosine Kinase ◽  
Cancer Cells ◽  
Receptor Tyrosine Kinase ◽  
Colorectal Cancer Cells ◽  
Kinase Phosphorylation

Sa1181 BCAR3 PARTNERS WITH THE EGF-RECEPTOR TYROSINE KINASE THROUGH ITS SH2 DOMAIN TO PROMOTE COLORECTAL CANCER CELL INVASIVENESS

2020 ◽  
Vol 158 (6) ◽  
pp. S-302
Author(s):  
David J. Fei-Zhang ◽  
Joshua J. Thompson ◽  
Mark R. Frey ◽  
Christopher S. Williams
Keyword(s):  
Colorectal Cancer ◽  
Tyrosine Kinase ◽  
Cancer Cell ◽  
Receptor Tyrosine Kinase ◽  
Egf Receptor ◽  
Sh2 Domain ◽  
Colorectal Cancer Cell ◽  
Cell Invasiveness ◽  
Cancer Cell Invasiveness
Sign in / Sign up

Export Citation Format

Share Document